Epidemiological study for hospitalized patients with community-acquired, health-care-associated, hospital-acquired, and ventilator-associated pneumonia in Japan: a prospective multicenter follow-up study (CJLSG 0911)

Not Applicable

• Conditions: community-acquired (CAP), health-care-associated (HCAP), hospital-acquired (HAP), and ventilator-associated pneumonia (VAP)

• Registration Number: JPRN-UMIN000003306
• Lead Sponsor: Central Japan Lung Study Group

Brief Summary

http://www.ncbi.nlm.nih.gov/pubmed/23855620

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2010-03-09
• Study Completion: 2011-05-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 1200

Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients who do not receive initial empirical antibiotic treatment 2) Patients with obstructive pneumonia 3) Pneumonia occurred in other hospitals and patients who were transferred from their hospitals with a tendency to improve 4) Patients whose pneumonia recurred within 3 days after the last day of antibiotic treatment of a preceding pneumonia episode 5) Patients who receive the treatment in an outpatient clinic 6) Patients who are less than 20 years old

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
1) 30-day mortality and in-hospital mortality 2) Identified pathogens and drug resistance 3) Early and late treatment failure 4) Appropriateness of antibiotic treatment 5) Outcomes and their clinical prediction rules for patients with each category of pneumonia (CAP, HCAP, HAP, and VAP) 6) Adherence to practice guidelines in initial empirical antibiotic treatment for patients with each category of pneumonia (CAP, HCAP, HAP, and VAP)